BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16962315)

  • 1. Multinational clinical trials in oncology and post-trial benefits for host countries: where do we stand?
    Mano MS; Rosa DD; Dal Lago L
    Eur J Cancer; 2006 Nov; 42(16):2675-7. PubMed ID: 16962315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should post-trial provision of beneficial experimental interventions be mandatory in developing countries?
    Zong Z
    J Med Ethics; 2008 Mar; 34(3):188-92. PubMed ID: 18316461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior agreements in international clinical trials: ensuring the benefits of research to developing countries.
    Page AK
    Yale J Health Policy Law Ethics; 2002; 3(1):35-66. PubMed ID: 12825426
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trials in developing countries: who should define ethics?].
    Béréterbide F; Hirsch F
    Bull Soc Pathol Exot; 2008 Apr; 101(2):102-5. PubMed ID: 18543701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical issues in the NIMH Collaborative HIV/STD Prevention Trial.
    NIMH Collaborative HIV/STD Prevention Trial Group
    AIDS; 2007 Apr; 21 Suppl 2():S69-80. PubMed ID: 17413266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conduct of clinical trials in developing countries: a perspective.
    Devasenapathy N; Singh K; Prabhakaran D
    Curr Opin Cardiol; 2009 Jul; 24(4):295-300. PubMed ID: 19444095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical trials in "developing" countries: is there a special "Third World" ethic?].
    Rothman DJ
    Z Arztl Fortbild Qualitatssich; 2003 Dec; 97(10):695-702. PubMed ID: 14997587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits to research subjects in international trials: do they reduce exploitation or increase undue inducement?
    Ballantyne A
    Dev World Bioeth; 2008 Dec; 8(3):178-91. PubMed ID: 19046255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research and developing countries: hopes and hypes.
    Moazam F
    East Mediterr Health J; 2006; 12 Suppl 1():S30-6. PubMed ID: 17037686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse effects of a multicentre system for ethics approval on the progress of a prospective multicentre trial of cancer treatment: how many patients die waiting?
    Christie DR; Gabriel GS; Dear K
    Intern Med J; 2007 Oct; 37(10):680-6. PubMed ID: 17894765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One size does not fit all: toward "upstream ethics"?
    Ozdemir V; Knoppers BM
    Am J Bioeth; 2010 Jun; 10(6):42-4. PubMed ID: 20526970
    [No Abstract]   [Full Text] [Related]  

  • 15. Moral standards for research in developing countries: from "reasonable availability" to "fair benefits".
    Participants in the 2001 Conference on Ethical Aspects of Research in Developing Countries
    Hastings Cent Rep; 2004; 34(3):17-27. PubMed ID: 15281723
    [No Abstract]   [Full Text] [Related]  

  • 16. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ontario Cancer Research Ethics Board: lessons learned from developing a multicenter regional institutional review board.
    Saginur R; Dent SF; Schwartz L; Heslegrave R; Stacey S; Manzo J
    J Clin Oncol; 2008 Mar; 26(9):1479-82. PubMed ID: 18349399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for trials of behavioral treatments for recurrent headache, first edition: American Headache Society Behavioral Clinical Trials Workgroup.
    Penzien DB; Andrasik F; Freidenberg BM; Houle TT; Lake AE; Lipchik GL; Holroyd KA; Lipton RB; McCrory DC; Nash JM; Nicholson RA; Powers SW; Rains JC; Wittrock DA;
    Headache; 2005 May; 45 Suppl 2():S110-32. PubMed ID: 15921503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assuring the ethical conduct of clinical cancer trials in the developing world.
    Markman M
    Cancer; 2006 Jan; 106(1):1-3. PubMed ID: 16302227
    [No Abstract]   [Full Text] [Related]  

  • 20. Fair benefits in international medical research.
    Arras JD
    Hastings Cent Rep; 2004; 34(3):3. PubMed ID: 15281717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.